559 related articles for article (PubMed ID: 25965287)
21. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
23. [Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG)].
Blanco Y; Hankiewicz K; Llufriu S; Sabater L; Graus F; Saiz A;
Neurologia; 2010; 25(1):5-12. PubMed ID: 20388455
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and classification of neuromyelitis optica (Devic's syndrome).
Drori T; Chapman J
Autoimmun Rev; 2014; 13(4-5):531-3. PubMed ID: 24424197
[TBL] [Abstract][Full Text] [Related]
25. Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).
Asgari N
Dan Med J; 2013 Oct; 60(10):B4730. PubMed ID: 24083534
[TBL] [Abstract][Full Text] [Related]
26. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
27. Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica.
Pereira WLCJ; Reiche EMV; Kallaur AP; Oliveira SR; Simão ANC; Lozovoy MAB; Schiavão LJV; Rodrigues PRDVP; Alfieri DF; Flauzino T; Kaimen-Maciel DR
Acta Neuropsychiatr; 2017 Jun; 29(3):170-178. PubMed ID: 27692000
[TBL] [Abstract][Full Text] [Related]
28. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
29. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Sato DK; Nakashima I; Takahashi T; Misu T; Waters P; Kuroda H; Nishiyama S; Suzuki C; Takai Y; Fujihara K; Itoyama Y; Aoki M
Neurology; 2013 Jun; 80(24):2210-6. PubMed ID: 23677744
[TBL] [Abstract][Full Text] [Related]
30. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
31. The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Lana-Peixoto MA; Callegaro D
Arq Neuropsiquiatr; 2012 Oct; 70(10):807-13. PubMed ID: 23060108
[TBL] [Abstract][Full Text] [Related]
32. Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
Absoud M; Lim MJ; Appleton R; Jacob A; Kitley J; Leite MI; Pike MG; Vincent A; Wassmer E; Waters P; Woodhall M; Hemingway C; Palace J
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):470-2. PubMed ID: 25091363
[TBL] [Abstract][Full Text] [Related]
33. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis.
Petzold A; Pittock S; Lennon V; Maggiore C; Weinshenker BG; Plant GT
J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):109-11. PubMed ID: 20019228
[TBL] [Abstract][Full Text] [Related]
34. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
[TBL] [Abstract][Full Text] [Related]
35. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
[TBL] [Abstract][Full Text] [Related]
36. Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.
Adoni T; Lino AM; da Gama PD; Apóstolos-Pereira SL; Marchiori PE; Kok F; Callegaro D
Mult Scler; 2010 Jan; 16(1):81-6. PubMed ID: 19995833
[TBL] [Abstract][Full Text] [Related]
37. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis.
Jiao Y; Fryer JP; Lennon VA; McKeon A; Jenkins SM; Smith CY; Quek AM; Weinshenker BG; Wingerchuk DM; Shuster EA; Lucchinetti CF; Pittock SJ
JAMA Neurol; 2014 Jan; 71(1):48-54. PubMed ID: 24248262
[TBL] [Abstract][Full Text] [Related]
38. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
[TBL] [Abstract][Full Text] [Related]
39. No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Xie L; Long Y; Yang N; Shan F; Fan Y; Zhong R; Wu L; Yin J; Gao Q; Cong G
Neuroimmunomodulation; 2015; 22(5):337-41. PubMed ID: 25721331
[TBL] [Abstract][Full Text] [Related]
40. NMO-IgG predicts the outcome of recurrent optic neuritis.
Matiello M; Lennon VA; Jacob A; Pittock SJ; Lucchinetti CF; Wingerchuk DM; Weinshenker BG
Neurology; 2008 Jun; 70(23):2197-200. PubMed ID: 18434643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
